Stocktoria
INTELLIGENT BIO SOLUTIONS INC. INBS
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-23
INTELLIGENT BIO SOLUTIONS INC. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | $3.1M | $1.3M | $437,146 | $2.0M | $188,744 |
| Gross profit | $1.2M | $1.4M | $326,668 | — | — | — |
| Operating income | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M | -$2.9M |
| Net income | -$10.6M | -$10.2M | -$10.6M | -$8.3M | -$7.0M | -$3.2M |
| EPS (diluted) | $-2.00 | $-6.38 | $-127.00 | $-11.33 | — | — |
| Operating cash flow | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M | -$498,618 |
| Free cash flow | -$9.9M | -$9.8M | — | — | — | — |
| Cash & equivalents | $1.0M | $6.3M | $1.5M | $8.2M | $12.6M | $427,273 |
| Inventory | $635,215 | $777,537 | $979,907 | — | — | — |
| Total assets | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M | $2.5M |
| Total liabilities | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M | $7.7M |
| Shareholders' equity | $3.0M | $8.3M | $3.8M | $6.6M | $15.1M | -$5.2M |
Growth · year-over-year · Revenue CAGR 74.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -1.9% | +147.6% | +187.5% | -77.9% | +949.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.